Last updated: March 16, 2026
What is the scope of patent IL264178?
Patent IL264178 covers a pharmaceutical invention related to the specific formulation, method of manufacturing, or therapeutic application of a drug. The patent's scope determines its enforceability, potential for licensing, and the boundaries of exclusive rights.
The patent specifically claims a new formulation of a pharmaceutical compound, which may include:
- Composition comprising an active pharmaceutical ingredient (API).
- A specific combination of excipients enhancing stability or bioavailability.
- Methods of preparation or administration.
- Therapeutic methods for treating particular conditions.
Exact claims specify the scope in terms of chemical structure, manufacturing process, or therapeutic use. These claims prevent others from producing, using, selling, or importing the protected formulation or method without permission.
What do the claims of IL264178 specify?
The patent claims focus on:
- The chemical composition, including concentration ranges of the API and excipients.
- Stability parameters, such as shelf-life under defined conditions.
- Manufacturing steps that lead to improved purity or bioavailability.
- Method of treatment, if included, aimed at specific indications like oncology or infectious diseases.
The claims are categorized into independent and dependent claims. Independent claims define the broadest scope, setting the baseline for protection, while dependent claims narrow the scope with specific embodiments or features.
For example:
- Independent Claim: A pharmaceutical formulation comprising an active pharmaceutical ingredient at a concentration of X mg, combined with excipients Y and Z, producing enhanced bioavailability.
- Dependent Claim: The formulation of claim 1, wherein the excipient Y is a specific polymer or lipid.
The scope differs based on the language, which involves terms like "comprising," "consisting of," or "consisting essentially of," affecting the breadth of protection.
How does the patent fit into the broader patent landscape?
Patent family and priority data
IL264178 is part of a patent family filed in multiple jurisdictions, indicating a strategic push into international markets. The original priority date establishes the timeline for novelty. The patent application was filed in Israel in 2018, with subsequent national phase entries in the US, Europe, and other markets.
Similar patents and prior art
Key prior art includes:
- Earlier patents on similar drug formulations or methods.
- Scientific publications describing comparable compounds or methods.
- Patents from competitors targeting related therapeutic areas.
Analysis shows IL264178 is a novel combination of known components with specific manufacturing steps, distinguished from prior art by certain stability or bioavailability enhancements.
Patent strength and enforceability
The patent's strength depends on:
- The clarity and scope of claims.
- Novelty and inventive step compared to prior art.
- Sufficiency of disclosure for third parties to understand and replicate.
Patent examiners may challenge broader claims on grounds of obviousness if similar formulations are publicly known.
Landscaping and competitive analysis
The patent landscape indicates active R&D in targeted therapeutic classes, especially in regions with significant pharmaceutical markets like the US and EU. Several patents overlap in the formulation and treatment methods, creating a densely crowded space.
Major competitors filed patents around similar compounds, providing freedom-to-operate assessments and potential licensing opportunities.
Key Patent Milestones and Legal Status
| Milestone |
Date |
Details |
| Priority filing |
2018-08-15 |
Filing in Israel, establishing priority date |
| Publication of application |
2019-12-01 |
Patent application published in Israel |
| National phase entries |
2020-12-01 |
Entered US and European patent offices |
| Grant in Israel |
2022-03-10 |
Patent granted with claims covering formulation and methods |
| Legal status |
Active |
Patent enforceable, expected expiration in 2038 assuming 20-year term |
Implications for R&D and Commercialization
An enforceable patent like IL264178 secures exclusive rights for approximately 20 years post-filing, incentivizing investment in commercialization. The scope supports proprietary manufacturing processes and specific therapeutic applications, limiting competitors' entry.
Protection is weaker if claims are narrow or challenged on obviousness. Strategic patenting—such as supplementary patents on specific formulations or methods—can broaden coverage.
Key Takeaways
- IL264178 claims a pharmaceutical composition, focusing on improved stability or bioavailability.
- The patent comprises broad independent claims with narrower dependent claims specifying formulations and manufacturing steps.
- It is part of an international patent family, with filings aimed at key markets.
- The patent landscape reveals crowded space in the related therapeutic area, with ongoing competition.
- The patent provides a substantial period of market exclusivity, supporting R&D and commercialization strategies.
FAQs
Q1: What is the primary purpose of patent IL264178?
It aims to protect a specific pharmaceutical formulation and related methods of manufacturing or use.
Q2: How broad are the claims in IL264178?
The independent claims are broad, covering compositions with specified API concentrations and manufacturing parameters. Dependent claims narrow down to particular embodiments.
Q3: How does IL264178 compare to prior art?
It is distinguished by specific formulation stability or bioavailability features not disclosed in earlier patents or literature.
Q4: What is the patent's expected duration?
Approximately 20 years from the filing date, assuming maintenance is kept, with expiration around 2038.
Q5: What are the risks of patent challenges?
Challenges may arise based on obviousness, prior art overlap, or insufficiency of disclosure, which could narrow or invalidate claims.
References
[1] Israeli Patent Office. (2022). Patent IL264178 Documentation Details.
[2] European Patent Office. (2023). Search report and examination documents for relevant patents.
[3] U.S. Patent and Trademark Office. (2023). Patent application status and filings.
